首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   253187篇
  免费   19833篇
  国内免费   837篇
耳鼻咽喉   3612篇
儿科学   7228篇
妇产科学   5172篇
基础医学   33674篇
口腔科学   5499篇
临床医学   27035篇
内科学   50671篇
皮肤病学   4057篇
神经病学   23942篇
特种医学   8793篇
外国民族医学   23篇
外科学   37067篇
综合类   3904篇
现状与发展   3篇
一般理论   266篇
预防医学   22066篇
眼科学   6531篇
药学   17871篇
  1篇
中国医学   272篇
肿瘤学   16170篇
  2021年   3521篇
  2020年   2460篇
  2019年   3924篇
  2018年   4697篇
  2017年   3395篇
  2016年   3888篇
  2015年   4610篇
  2014年   6629篇
  2013年   10273篇
  2012年   14609篇
  2011年   15721篇
  2010年   8685篇
  2009年   8089篇
  2008年   14526篇
  2007年   15590篇
  2006年   14982篇
  2005年   15366篇
  2004年   14543篇
  2003年   13821篇
  2002年   13359篇
  2001年   4137篇
  2000年   3842篇
  1999年   3858篇
  1998年   2847篇
  1997年   2377篇
  1996年   2088篇
  1995年   2271篇
  1994年   2136篇
  1993年   2001篇
  1992年   3061篇
  1991年   2948篇
  1990年   2693篇
  1989年   2635篇
  1988年   2565篇
  1987年   2463篇
  1986年   2482篇
  1985年   2548篇
  1984年   2542篇
  1983年   2359篇
  1982年   2396篇
  1981年   2161篇
  1980年   1963篇
  1979年   1935篇
  1978年   1736篇
  1977年   1509篇
  1976年   1377篇
  1975年   1254篇
  1974年   1424篇
  1973年   1198篇
  1972年   1095篇
排序方式: 共有10000条查询结果,搜索用时 156 毫秒
21.
22.
23.
24.
25.
26.
27.

Objective

To investigate the efficacy and safety of an influenza vaccination in patients with myasthenia gravis with acetylcholine receptor antibodies (AChR MG).

Methods

An influenza vaccination or placebo was administered to 47 AChR MG patients. Before and 4?weeks after administration blood samples and clinical outcome scores were obtained. Antibodies to the vaccine strains A/California/7/2009 (H1N1)pdm09, A/Hong Kong/4801/14 (H3N2) and B/Brisbane/060/08 were measured using the hemagglutination-inhibition (HI) assay and disease-specific AChR antibody titers were measured with a radio-immunoprecipitation assay. Forty-seven healthy controls (HC) were vaccinated with the same influenza vaccine to compare antibody titers.

Results

A post-vaccination, seroprotective titer (HI?≥?1:40) was achieved in 89.4% of MG patients vs. 93.6% in healthy controls for the H3N2 strain, 95.7% vs 97.9% for the H1N1 strain and 46.8 vs 51% for the B-strain. A seroprotective titer for all three strains of the seasonal influenza vaccine was reached in 40.4% (19/47) of the MG group and in 51% (24/47) of the HC group. Immunosuppressive medication did not significantly influence post geomean titers (GMT). The titers of disease-specific AChR antibodies were unchanged 4?weeks after vaccination. The clinical outcome scores showed no exacerbation of MG symptoms.

Conclusion

The antibody response to an influenza vaccination in patients with AChR MG was not different from that in healthy subjects, even in AChR MG patients using immunosuppressive medication. Influenza vaccination does not induce an immunological or clinical exacerbation of AChR MG.

Clinical trial registry

The influenza trial is listed on clinicaltrialsregister.eu under 2016-003138-26.  相似文献   
28.
29.
Undergraduate medical education has expanded substantially in recent years, through both establishing new programs and increasing student numbers in existing programs. This expansion has placed pressure on the capacity for training students in clinical placements, raising concerns about the risk of dilution of experience, and reducing work readiness. The concerns have been greatest in more traditional environments, where clinical placements in large academic medical centers are often the “gold standard”. However, there are ways of exposing medical students to patient interactions and clinical supervisors in many other contexts. In this paper, we share our experiences and observations of expanding clinical placements for both existing and new medical programs in several international locations. While this is not necessarily an easy task, a wide range of opportunities can be accessed by asking the right questions of the right people, often with only relatively modest changes in resource allocation.  相似文献   
30.
Steady-state axisymmetric simulations using the Reynolds-Averaged Navier-Stokes equations have been carried out in order to optimize the performance of a Chemical, Biological, Radiological, and Nuclear (CBRN) canister filter for its use in a powered air-purifying respirator (PAPR). Alterations have been made to the shape of the canister, the spacing of the rear wall of the canister with regard to the carbon filter, and the bracketing between (i) the particulate filter and the carbon bed and (ii) the carbon bed and the canister wall. The pressure drops across the canister and the residence time distribution at the rear of the carbon bed have been analyzed in detail based on an extensive parametric analysis involving the aforementioned variations. It has been demonstrated that the non-uniform porosity profile of the carbon bed resulted in alternating regions of high and low velocity close to the canister wall, providing a possible route for breakthrough. Designs, which included a bracket at the rear of the carbon bed, blocked this route and consequently had a longer minimum mean residence time than those, which did not. It has also been shown that the spacing between the carbon bed and the canister rear wall had a large impact on both residence time and pressure drop. In cases where the carbon backed directly onto the canister rear wall flow in the axial direction from the outside wall toward the canister axis resulted in far greater pressure drop and a reduction in minimum mean residence time within the carbon bed.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号